Schedule 13D ownership disclosure

Immunovant Inc

Security class unavailable · CUSIP: 45258J102

Event date: 2020-05-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
47,223,419
Percent of class
62.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-061794
Form type
SC 13D/A
Filer
Immunovant, Inc.
CIK
CIK 1764013
Filed
May 15, 2020
Reporting period
May 12, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub